Target Announces Extra Hours, More Pay, Flexibility For Current Stores Team Members

Target Corporation (TGT) said it will provide five million more hours to current stores team members this holiday shopping season, which would result in more than $75 million more in pay. All store team members can easily pick up additional hours and switch available shifts, through a mobile scheduling app. Also, the company will hire fewer seasonal team members than previous years as it invests in more flexible scheduling, pay and benefits for current team.

The company will hire 100,000 seasonal team members at its stores across the country to supplement its current team. Target Corp. noted that many seasonal team members will have the opportunity to remain with the company following the holiday season.

"When we invest in and care for our team we know that guest service improves, turnover goes down and team members can more easily build rewarding careers at Target," said Melissa Kremer, chief human resources officer, Target.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT